Expert Witness for Litigation

The Food and Drug Administration is forecasting a future requirement for an expert witness to provide specialized testimony in support of litigation matters. This opportunity falls under the NAICS code 541199 for other scientific and technical consulting services and is positioned as a forecasted contract action with no solicitation number yet assigned. The work will involve providing authoritative, science-based expert testimony relevant to FDA’s regulatory and legal proceedings, likely requiring deep domain expertise in areas such as pharmaceuticals, medical devices, biologics, or public health science. The point of contact for program inquiries is the Cder Acquisition Liaison, reachable at cderacquisitions@fda.hhs.gov, while the contracting officer position is currently listed as to be determined. There is no specified place of performance or set-aside designation, suggesting the work may be performed remotely or at various locations as needed, and no preference for small business or other socio-economic categories has been indicated. The opportunity was posted on May 25, 2026, and interested parties should monitor the official HHS OSDBU portal for future solicitation details.